ArabFinance: Misr For Central Clearing, Depository & Registry has stated spare money under the account of Rameda Pharmaceutical's (RMDA) Initial Public Offering (IPO) will be refunded on the morning of Thursday, December 5, 2019.
The offering manager asked to execute the public offering and private placement on Dec 08, 2019 and start trading on Dec. 11, 2019.
Rameda Pharmaceutical's public offering was covered about 36 times, therefore, the allotment is about 2.7% for each bid.